Now that stock investors are beginning to realize that a recession isn't on the way, the U.S. market will get back to doing what is up to before the August swoon: showing strength beyond the Magnificent Seven.

Intuitive Surgical is sailing against a few new headwinds. So far its financial performance hasn't been severely impacted.

Intuitive Surgical's da Vinci robots help doctors perform surgeries with fewer errors. Procedure growth is impressive, driving revenue for the company's instruments and accessories.

Intuitive Surgical (ISRG) is making strides in the robotic-assisted surgery market with its existing and new launches. However, macro challenges are likely to continue to hurt its performance.

Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line, but that's not the case at the moment. Robots have yet to replace human surgeons.

Healthcare and beauty spending tend to remain resilient in a wide range of economic environments. Intuitive Surgical has a vast moat, and growth is accelerating despite near-term challenges beyond its control.

Regardless of market fluctuations, it's always a good time to invest in quality companies. Intuitive Surgical has a simple but effective business model that is driving impressive growth.

Johnson & Johnson hasn't performed that well in the past decade. By contrast, Vertex Pharmaceuticals and Intuitive Surgical have been exceptional.

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

A leader in surgical robotics and an innovative travel specialist are both faring well in the current environment. Intuitive Surgical is raking in robust profits and revenue growth from its flagship products.

If you are looking for AI-related stocks you can buy and hold forever, look no further than this list. The stocks on this list are applying AI, and the application of AI counts.

There are a whole host of reasons to invest in healthcare stocks over the long term. The United States has an aging population.